Aloqaily Mohammed, Tarazi Alaa, Ammar Abdullah, Alfarrajin Ibrahim, Ababneh Raed, Aloqaily Wafi A, Alasaad Yousef
Internal Medicine, University of Maryland Medical Center, Baltimore, USA.
Medicine, The University of Jordan, Amman, JOR.
Cureus. 2025 Feb 7;17(2):e78701. doi: 10.7759/cureus.78701. eCollection 2025 Feb.
Hiccups manifest as involuntary and repetitive diaphragm contractions, often involving the intercostal muscles. However, the precise underlying mechanism remains incompletely understood but typically benign. During the COVID-19 pandemic, the predominant clinical presentation featured fever, cough, and dyspnea. However, multiple atypical presentations are increasingly recognized as manifestations of COVID-19, including refractory hiccups. This article aims to examine the shared characteristics, distinctions, notable correlations, and prognosis among COVID-19 patients presenting with intractable hiccups. Additionally, we present a 79-year-old male with a history of Parkinson's disease, hypertension, and diabetes who presented with refractory hiccups, cough, and a runny nose. Laboratory analysis revealed elevated inflammatory markers and a positive COVID-19 test. The patient responded well to medical management, and the hiccups were resolved. Notably, the association between persistent hiccups and COVID-19 infection is increasingly recognized, predominantly affecting older males with comorbidities and can be the sole complaint. Furthermore, we analyzed 29 cases of COVID-19 with persistent hiccups in the English literature. The mean duration of symptoms was 3.9 days with the majority of these cases being males (96.55%) and an average age of affected individuals of 58.28 years. Cough was the most frequently associated symptom (31.03%), while an equal proportion of patients (31.03%) reported intractable hiccups as their sole complaint. Additionally, common findings included elevated inflammatory markers, electrolyte imbalances, and infiltrates on imaging. Most of the patients demonstrated substantial improvement through symptomatic and medical management; however, mortality was documented in two cases, which highlights the potential for this seemingly benign manifestation to mislead and necessitate thorough evaluation upon presentation.
打嗝表现为膈肌不自主的重复性收缩,常累及肋间肌。然而,其确切的潜在机制仍未完全明了,但通常为良性。在新冠疫情期间,主要临床表现为发热、咳嗽和呼吸困难。然而,多种非典型表现越来越多地被认为是新冠的表现,包括顽固性打嗝。本文旨在研究新冠患者出现顽固性打嗝时的共同特征、差异、显著相关性及预后。此外,我们报告了一名79岁男性,有帕金森病、高血压和糖尿病病史,出现顽固性打嗝、咳嗽和流鼻涕症状。实验室分析显示炎症标志物升高且新冠检测呈阳性。该患者对药物治疗反应良好,打嗝症状得以缓解。值得注意的是,持续性打嗝与新冠感染之间的关联越来越受到认可,主要影响有合并症的老年男性,且可能是唯一的主诉。此外,我们分析了英文文献中29例伴有持续性打嗝的新冠病例。症状的平均持续时间为3.9天,这些病例大多数为男性(96.55%),受影响个体的平均年龄为58.28岁。咳嗽是最常伴随的症状(31.03%),而同等比例的患者(31.03%)报告称顽固性打嗝是他们唯一的主诉。此外,常见表现包括炎症标志物升高、电解质失衡以及影像学上的浸润影。大多数患者通过对症和药物治疗有显著改善;然而,有两例记录了死亡情况,这凸显了这种看似良性的表现可能产生误导,且在出现症状时需要进行全面评估。